Published in World J Gastrointest Endosc on April 16, 2015
Rare Neoplasia of the Stomach. Gastrointest Tumors (2015) 0.79
Management of gastric and duodenal neuroendocrine tumors. World J Gastroenterol (2016) 0.75
Insights into gastric neuroendocrine tumors burden. Chin J Cancer Res (2017) 0.75
One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol (2008) 15.05
TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Arch (2006) 5.86
Three subtypes of gastric argyrophil carcinoid and the gastric neuroendocrine carcinoma: a clinicopathologic study. Gastroenterology (1993) 4.04
Helicobacter pylori infection and chronic gastric acid hyposecretion. Gastroenterology (1997) 3.16
Relationships among serum pepsinogen I, serum pepsinogen II, and gastric mucosal histology. A study in relatives of patients with pernicious anemia. Gastroenterology (1982) 3.05
The epidemiology of gastroenteropancreatic neuroendocrine tumors. Endocrinol Metab Clin North Am (2011) 2.95
Plasma gastrin and gastric enterochromaffinlike cell activation and proliferation. Studies with omeprazole and ranitidine in intact and antrectomized rats. Gastroenterology (1986) 2.46
Review article: the investigation and management of gastric neuroendocrine tumours. Aliment Pharmacol Ther (2014) 2.28
Epidemiological study of gastroenteropancreatic neuroendocrine tumors in Japan. J Gastroenterol (2010) 2.18
Inappropriate hypergastrinaemia in asymptomatic healthy subjects infected with Helicobacter pylori. Gut (1990) 2.13
Gastric carcinoids: biologic behavior and prognosis after differentiated treatment in relation to type. Ann Surg (2005) 1.99
Endoscopic mucosal resection in the management of gastric carcinoid tumors. Endoscopy (2003) 1.95
Neuroendocrine tumors. J Natl Compr Canc Netw (2012) 1.91
Gastroenteropancreatic neuroendocrine tumours: the current incidence and staging based on the WHO and European Neuroendocrine Tumour Society classification: an analysis based on prospectively collected parameters. Endocr Relat Cancer (2010) 1.85
Antigenic mimicry between Helicobacter pylori and gastric mucosa in the pathogenesis of body atrophic gastritis. Gastroenterology (1996) 1.83
Current Trends of the Incidence and Pathological Diagnosis of Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) in Korea 2000-2009: Multicenter Study. Cancer Res Treat (2012) 1.76
Diagnosis of submucosal tumor of the upper GI tract by endoscopic resection. Gastrointest Endosc (1999) 1.71
Mutations of RegIalpha are associated with enterochromaffin-like cell tumor development in patients with hypergastrinemia. Gastroenterology (1999) 1.70
ENETS Consensus Guidelines for the management of patients with gastroduodenal neoplasms. Neuroendocrinology (2012) 1.68
A 50-year analysis of 562 gastric carcinoids: small tumor or larger problem? Am J Gastroenterol (2004) 1.67
Carcinoid tumors of the gastrointestinal tract: trends in incidence in England since 1971. Am J Gastroenterol (2010) 1.65
Neuroendocrine tumors of the stomach (gastric carcinoids) are on the rise: small tumors, small problems? Endoscopy (2010) 1.60
Treatment of gastric carcinoids type 1 with the gastrin receptor antagonist netazepide (YF476) results in regression of tumours and normalisation of serum chromogranin A. Aliment Pharmacol Ther (2012) 1.57
Microcarcinoid tumor diagnosed with high-resolution magnification endoscopy and narrow band imaging. Endoscopy (2008) 1.45
Accuracy of EUS in the evaluation of small gastric subepithelial lesions. Gastrointest Endosc (2010) 1.43
Long-term results of endoscopic resection for type I gastric neuroendocrine tumors. J Surg Oncol (2013) 1.43
Omeprazole in oesophageal reflux disease. Lancet (2000) 1.41
The gastric H+,K+-ATPase is a major autoantigen in chronic Helicobacter pylori gastritis with body mucosa atrophy. Gastroenterology (1998) 1.26
Prognosis of gastric carcinoid tumours. Digestion (1995) 1.23
Histologic characterization and improved prognostic evaluation of 209 gastric neuroendocrine neoplasms. Hum Pathol (2011) 1.22
Autoimmune gastritis in type 1 diabetes: a clinically oriented review. J Clin Endocrinol Metab (2007) 1.20
Long-term follow up of patients with multiple gastric carcinoids associated with type A gastritis. Gastric Cancer (2005) 1.15
Antigastric autoantibodies in Helicobacter pylori infection: implications of histological and clinical parameters of gastritis. Gut (1997) 1.13
Type I gastric carcinoids: a prospective study on endoscopic management and recurrence rate. Neuroendocrinology (2011) 1.08
Clinical symptoms, hormone profiles, treatment, and prognosis in patients with gastric carcinoids. Gut (1998) 1.07
Distinct patterns of chronic gastritis associated with carcinoid and cancer and their role in tumorigenesis. Yale J Biol Med (1994) 1.07
Current concepts on gastric carcinoid tumors. Gastroenterol Res Pract (2012) 1.04
Treatment of gastric neuroendocrine tumors: the necessity of a type-adapted treatment. Arch Surg (2001) 0.99
Management of patients with Zollinger-Ellison syndrome. Annu Rev Med (1995) 0.98
Presentation, treatment, and outcome of type 1 gastric carcinoid tumors. J Surg Oncol (2006) 0.97
Tumor size and depth predict rate of lymph node metastasis and utilization of lymph node sampling in surgically managed gastric carcinoids. Ann Surg Oncol (2011) 0.96
Review of the pathogenesis, diagnosis, and management of type I gastric carcinoid tumor. World J Surg (2011) 0.94
Distribution, incidence, and prognosis in neuroendocrine tumors: a population based study from a cancer registry. Pathol Oncol Res (2011) 0.94
Standard imaging techniques for neuroendocrine tumors. Endocrinol Metab Clin North Am (2011) 0.93
Typical carcinoids and neuroendocrine carcinomas of the stomach: differing clinical courses and prognoses. Am J Surg (2010) 0.93
Long-term follow-up of a large series of patients with type 1 gastric carcinoid tumors: data from a multicenter study. Eur J Endocrinol (2013) 0.92
Gastric endocrine tumors type I: treatment with long-acting somatostatin analogs. Endocr Relat Cancer (2008) 0.91
Gastrin increases mcl-1 expression in type I gastric carcinoid tumors and a gastric epithelial cell line that expresses the CCK-2 receptor. Am J Physiol Gastrointest Liver Physiol (2008) 0.90
Diverse clinical and pathologic features of gastric carcinoid and the relevance of hypergastrinemia. World J Surg (1995) 0.90
Classification, clinicopathologic features and treatment of gastric neuroendocrine tumors. World J Gastroenterol (2014) 0.89
Gastric and duodenal neuroendocrine tumours. Best Pract Res Clin Gastroenterol (2012) 0.89
Gastric carcinoid tumors without autoimmune gastritis in Japan: a relationship with Helicobacter pylori infection. Dig Dis Sci (2002) 0.88
Helicobacter pylori lipopolysaccharide stimulates histamine release and DNA synthesis in rat enterochromaffin-like cells. Gastroenterology (1997) 0.86
Defining surgical indications for type I gastric carcinoid tumor. Ann Surg Oncol (2009) 0.86
Human gastric carcinoid detected during long-term antiulcer therapy of H2 receptor antagonist and proton pump inhibitor. Dig Dis Sci (1998) 0.85
Long-term endoscopic and clinical follow-up of untreated type 1 gastric neuroendocrine tumours. Dig Liver Dis (2007) 0.85
Long-acting somatostatin analogues are an effective treatment for type 1 gastric carcinoid tumours. Eur J Endocrinol (2008) 0.85
Loss of heterozygosity in 11q13-14 regions in gastric neuroendocrine tumors not associated with multiple endocrine neoplasia type 1 syndrome. Lab Invest (1999) 0.85
Gastric carcinoids after long-term use of a proton pump inhibitor. Aliment Pharmacol Ther (2012) 0.85
Metastatic type 1 gastric carcinoid: a real threat or just a myth? World J Gastroenterol (2013) 0.85
Development of type I gastric carcinoid in patients with chronic atrophic gastritis. Aliment Pharmacol Ther (2011) 0.84
Gastric carcinoids: between underestimation and overtreatment. World J Gastroenterol (2009) 0.83
Ability of somatostatin receptor scintigraphy to identify patients with gastric carcinoids: a prospective study. J Nucl Med (2000) 0.82
Gastrin has a specific proliferative effect on the rat enterochromaffin-like cell, but not on the parietal cell: a study by elutriation centrifugation. Acta Physiol Scand (2000) 0.81
Clinical profiles, endoscopic and laboratory features and associated factors in patients with autoimmune gastritis. Digestion (2012) 0.81
Five-year follow-up of patients treated for 1 year with octreotide long-acting release for enterochromaffin-like cell carcinoids. Scand J Gastroenterol (2010) 0.80
Usefulness of endoscopic submucosal dissection for type I gastric carcinoid tumors compared with endoscopic mucosal resection. Hepatogastroenterology (2013) 0.79
Management and clinical outcomes of type I gastric carcinoid patients: retrospective, multicenter study in Japan. Dig Endosc (2013) 0.78
Primary biliary cirrhosis and gastric carcinoid: a rare association? J Clin Gastroenterol (1997) 0.78
The association between autoimmune thyroiditis, autoimmune gastritis and type 1 diabetes. Pediatr Endocrinol Rev (2003) 0.77
The efficacy of endoscopic submucosal dissection of type I gastric carcinoid tumors compared with conventional endoscopic mucosal resection. Gastroenterol Res Pract (2014) 0.76
Current concepts in the diagnosis and management of type 1 gastric neuroendocrine neoplasms. Clin Endocrinol (Oxf) (2014) 0.76